secwatch.observer — SEC 8-K summary
======================================

Issuer:     TREACE MEDICAL CONCEPTS, INC. (TMCI)
CIK:        0001630627
Form:       8-K
Filed at:   2025-04-07T23:59:59+00:00
Accession:  0000950170-25-051362
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

James Treace to retire from board; CEO John Treace appointed chairman effective May 20, 2025
--------------------------------------------------------------------------------

- James T. Treace to retire from board at 2025 annual meeting (expected May 20, 2025); departure not related to any disagreement.
- Board appoints CEO & Founder John T. Treace as Chairman, effective immediately after the 2025 annual meeting.
- Board size decreases from nine to eight directors upon James Treace's retirement.
- Lead independent director Richard W. Mott will continue in his role.
- No change in John T. Treace's compensation in connection with appointment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1630627/000095017025051362/0000950170-25-051362-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1630627/000095017025051362/tmci-20250407.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-051362

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer